April 20, 2022 -- Applied Cells and Stemcell Technologies are collaborating to combine Applied Cells' Multiphysics Automated Reconfigurable Separation (MARS) platform with Stemcell's EasySep immunomagnetic cell separation kit to advance tumor biology, genomics analyses, and cell therapy applications.
Adding Stemcell's cell isolation kits to the MARS cell isolation workflow will help researchers to automate and increase the efficiency of isolating high-quality cells from a wide range of sample types and extremely low-frequency cells from human samples.